D
David Gerhold
Researcher at Merck & Co.
Publications - 11
Citations - 1237
David Gerhold is an academic researcher from Merck & Co.. The author has contributed to research in topics: Peroxisome proliferator-activated receptor & Human genome. The author has an hindex of 7, co-authored 11 publications receiving 1181 citations.
Papers
More filters
Journal ArticleDOI
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium
Frank Dieterle,Frank D. Sistare,Federico Goodsaid,Marisa Papaluca,Josef S Ozer,Josef S Ozer,Craig P. Webb,William Baer,Anthony J. Senagore,Matthew J. Schipper,Jacky Vonderscher,Stefan Sultana,David Gerhold,Jonathan A. Phillips,Gerard Maurer,Kevin Carl,David Laurie,Ernie Harpur,Manisha Sonee,Daniela Ennulat,Dan Holder,Dina Andrews-Cleavenger,Yi Zhong Gu,Karol L. Thompson,Peter L. Goering,Jean Marc Vidal,Eric Abadie,Romaldas Mačiulaitis,David Jacobson-Kram,Albert F. Defelice,Elizabeth Hausner,Melanie Blank,Aliza Thompson,Patricia Harlow,Douglas C. Throckmorton,Shen Xiao,Nancy Xu,William Taylor,Spiros Vamvakas,Bruno Flamion,Beatriz Silva Lima,Peter Kasper,Markku Pasanen,Markku Pasanen,Krishna Prasad,Sean P. Troth,Denise Bounous,Denise Robinson-Gravatt,Graham Betton,Myrtle Davis,Jackie Akunda,James Eric McDuffie,Laura Suter,Leslie A. Obert,Magalie Guffroy,Mark Pinches,Supriya Jayadev,Eric A.G. Blomme,Sven A. Beushausen,Valérie G. Barlow,Nathaniel Collins,Nathaniel Collins,Jeff Waring,David Honor,Sandra Snook,Jinhe Lee,Phil Rossi,Elizabeth G. Walker,William B. Mattes +68 more
TL;DR: This was a pilot process, and the experience gained will both facilitate better understanding of how the qualification process will probably evolve and clarify the minimal requirements necessary to evaluate the performance of biomarkers of organ injury within specific contexts.
Journal ArticleDOI
The External RNA Controls Consortium: a progress report.
Shawn C. Baker,Steven R. Bauer,Richard P. Beyer,James D. Brenton,Bud Bromley,John Burrill,Helen C. Causton,Michael P Conley,Rosalie K. Elespuru,Michael J. Fero,Carole Foy,James C. Fuscoe,Xiaolian Gao,David Gerhold,Patrick Gilles,Federico Goodsaid,Xu Guo,Joe Hackett,Richard D. Hockett,Pranvera Ikonomi,Rafael A. Irizarry,Ernest S. Kawasaki,Tamma Kaysser-Kranich,Kathleen F. Kerr,Gretchen L. Kiser,Walter H. Koch,Kathy Y Lee,Chunmei Liu,Z. Lewis Liu,Anne Bergstrom Lucas,Chitra Manohar,Garry Miyada,Zora Modrusan,Helen Parkes,Raj K. Puri,Laura H. Reid,Thomas B. Ryder,Marc L. Salit,Raymond R. Samaha,Uwe Scherf,Timothy J Sendera,Robert Setterquist,Leming Shi,Richard Shippy,Jesus Soriano,Elizabeth A. Wagar,Janet A. Warrington,Mickey Williams,Frederike Wilmer,Michael A Wilson,Paul K. Wolber,Xiaoning Wu,Renata Zadro +52 more
TL;DR: The External RNA Controls Consortium (ERCC) is developing commonly agreed-upon and tested controls for use in expression assays, a true industry-wide standard control.
Journal ArticleDOI
DNA chips: promising toys have become powerful tools
TL;DR: In this paper, hybridization of RNA or DNA-derived samples to DNA chips allows us to monitor expression of mRNAs or the occurrence of polymorphisms in genomic DNA, which holds great promise for identifying gene polymorphisms that predispose man to disease, gene regulation events involved in disease progression, and more effective disease treatments.
Journal ArticleDOI
It's the genes! EST access to human genome content
David Gerhold,C. Thomas Caskey +1 more
TL;DR: There is a compelling need to build on the informatic synthesis of human gene data, and to devise facile methods for determining gene functions.
Journal ArticleDOI
PPARα Agonists Reduce 11β-Hydroxysteroid Dehydrogenase Type 1 in the Liver
Anne Hermanowski-Vosatka,David Gerhold,Steven S. Mundt,Vilert A. Loving,Meiqing Lu,Yuli Chen,Alex Elbrecht,Margaret Wu,Thomas W. Doebber,Linda J. Kelly,Denise P. Milot,Qiu Guo,Pei-Ran Wang,Marc C. Ippolito,Yu-Sheng Chao,Samuel D. Wright,Rolf Thieringer +16 more
TL;DR: These results are the first to show PPARα agonists can affect glucocorticoid metabolism in the liver by altering 11βHSD1 expression after chronic treatment, consistent with reports of their antidiabetic effects.